Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shengbai Oral Liquid vs Leucogen Tablets for Neutropenia in Breast Cancer
NCT07578064Phase 4Recruiting
- Sponsor
- Hongxia Wang
- Start
- Aug 2025
- Primary completion
- Sep 2026
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of Shengbai oral liquid in neutropenia, sponsored by Hongxia Wang. Started Aug 2025; status: recruiting.
02
Drugs
Shengbai oral liquid
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT07578064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07578064.